Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, A. Hamid Boulares et al.|British Journal of Pharmacology|2017Cited by 210
PDZK1 Is a Novel Factor in Breast Cancer That Is Indirectly Regulated by Estrogen through IGF-1R and Promotes Estrogen-Mediated GrowthHogyoung Kim, A. Hamid Boulares|Molecular Medicine|2013Cited by 101
PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell functionMohamed A. Ghonim, A. Hamid Boulares|Journal of Translational Medicine|2015Cited by 48
Correlation between PDZK1, Cdc37, Akt and Breast Cancer Malignancy: The Role of PDZK1 in Cell Growth through Akt Stabilization by Increasing and Interacting with Cdc37Hogyoung Kim, A. Hamid Boulares|Molecular Medicine|2014Cited by 40
PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in miceMohamed A. Ghonim, A. Hamid Boulares|Clinical Science|2015Cited by 38